- ￥7300
- GeneTex
- 美国
- GTX83442
- 2025年07月12日
- WB, ICC/IF, FACS
- Mouse
- Human
企业认证
相关产品推荐更多 >
![Histone H3S10ph (phospho Ser10) antibody [GT1195]](https://img1.dxycdn.com/2023/0711/451/6106825198874858761-14.jpg!wh200)
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Full length human recombinant protein of human UCK1 (NP_113620) produced in HEK293T cell.
- 亚型：
IgG1
- 形态：
Liquid
- 保存条件：
Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4ºC. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles.
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Human
- 保质期：
12 months from the shipping date of the product.
- 抗原来源：
Human
- 目录编号：
GTX83442
- 级别：
Primary Antibodies
- 库存：
Available
- 供应商：
GeneTex
- 宿主：
Mouse
- 应用范围：
WB, ICC/IF, FACS
- 浓度：
0.43 mg/ml (Please refer to the vial label for the specific concentration.)
- 靶点：
UCK1
- 抗体英文名：
UCK1 antibody [1A12]
- 抗体名：
UCK1 抗体 [1A12]
- 规格：
100 μl
FACS analysis of HeLa cells using GTX83442 UCK1 antibody [1A12].
Red : Primary antibody
Blue : Negative control antibody
WB analysis of HEK293T cells transfected with UCK1 plasmid (Right) or empty vector (Left) for 48 hrs using GTX83442 UCK1 antibody [1A12].
Loading : 5 ug per lane
FACS analysis of Jurkat cells using GTX83442 UCK1 antibody [1A12].
Red : Primary antibody
Blue : Negative control antibody
ICC/IF analysis of HeLa cells using GTX83442 UCK1 antibody [1A12].
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验ELISPOT (Enzyme-linked ImmunoSPOT)
of cytokine-producing cells at the single cell level. The method employs the sandwich assay approach of the enzyme-linked immunosorbent assay (ELISA), with some variations. The ELISPOT capture antibody is coated aseptically onto a polyvinylidene difluoride
Neutralizing Bioassay Protocols
describe in vitro bioassays using neutralizing anti-mouse and anti-human cytokine antibodies. In general, the cytokine bioassay protocols are modified to pre-incubate the cytokine of interest with the specific neutralizing antibody prior to addition
技术资料暂无技术资料 索取技术资料
